2367 logo

Giant Biogene Holding SHSC:2367 Stock Report

Last Price

HK$80.60

Market Cap

HK$85.3b

7D

0.1%

1Y

53.4%

Updated

10 May, 2025

Data

Company Financials +

Giant Biogene Holding Co., Ltd.

SHSC:2367 Stock Report

Market Cap: HK$85.3b

2367 Stock Overview

An investment holding company, designs, develops, and manufactures skin treatment products with recombinant collagen in the People’s Republic of China. More details

2367 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth6/6
Past Performance4/6
Financial Health6/6
Dividends2/6

Rewards

Trading at 22.3% below our estimate of its fair value

Earnings are forecast to grow 20.52% per year

Earnings grew by 42.1% over the past year

Risk Analysis

High level of non-cash earnings

Significant insider selling over the past 3 months


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Giant Biogene Holding Co., Ltd. Competitors

Mao Geping Cosmetics

SEHK:1318

HK$50.8b

Shanghai Chicmax Cosmetic

SEHK:2145

HK$27.4b

Hengan International Group

SEHK:1044

HK$26.0b

Golden Throat Holdings Group

SEHK:6896

HK$3.5b

Price History & Performance

Summary of share price highs, lows and changes for Giant Biogene Holding
Historical stock prices
Current Share PriceHK$80.60
52 Week HighHK$83.35
52 Week LowHK$35.00
Beta0.84
1 Month Change17.92%
3 Month Change38.73%
1 Year Change53.38%
3 Year Changen/a
5 Year Changen/a
Change since IPO147.62%

Recent News & Updates

Recent updates

Shareholder Returns

2367HK Personal ProductsHK Market
7D0.1%-0.04%1.4%
1Y53.4%24.3%11.3%

Return vs Industry: 2367 exceeded the Hong Kong Personal Products industry which returned 24.3% over the past year.

Return vs Market: 2367 exceeded the Hong Kong Market which returned 11.3% over the past year.

Price Volatility

Is 2367's price volatile compared to industry and market?
2367 volatility
2367 Average Weekly Movement7.5%
Personal Products Industry Average Movement7.1%
Market Average Movement8.1%
10% most volatile stocks in HK Market15.4%
10% least volatile stocks in HK Market4.3%

Stable Share Price: 2367 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 2367's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20001,758Jianya Yanwww.xajuzi.com

Giant Biogene Holding Co., Ltd., an investment holding company, designs, develops, and manufactures skin treatment products with recombinant collagen in the People’s Republic of China. It also develops and manufactures rare ginsenosides technology-based functional food products; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional food products primarily under the Comfy, Collgene, Ke Yu, and SKIGIN brands.

Giant Biogene Holding Co., Ltd. Fundamentals Summary

How do Giant Biogene Holding's earnings and revenue compare to its market cap?
2367 fundamental statistics
Market capHK$85.33b
Earnings (TTM)HK$2.22b
Revenue (TTM)HK$5.95b

38.5x

P/E Ratio

14.3x

P/S Ratio

Is 2367 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2367 income statement (TTM)
RevenueCN¥5.54b
Cost of RevenueCN¥991.90m
Gross ProfitCN¥4.55b
Other ExpensesCN¥2.48b
EarningsCN¥2.06b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.95
Gross Margin82.09%
Net Profit Margin37.23%
Debt/Equity Ratio0%

How did 2367 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

29%

Payout Ratio

Does 2367 pay a reliable dividends?

See 2367 dividend history and benchmarks
When do you need to buy 2367 by to receive an upcoming dividend?
Giant Biogene Holding dividend dates
Ex Dividend DateJun 17 2025
Dividend Pay DateAug 29 2025
Days until Ex dividend36 days
Days until Dividend pay date109 days

Does 2367 pay a reliable dividends?

See 2367 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/10 13:49
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Giant Biogene Holding Co., Ltd. is covered by 25 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ethan CuiBofA Global Research
Zhuonan XuChina International Capital Corporation Limited
Joseph WongChina Merchants Securities (HK) Co., Ltd